Health TrialsbyHealthPanel

Comparative Evaluation of Eggshell Powder in Primary Teeth Pulpotomy

ConditionsPulpitis ReversiblePulp Exposure, Dental
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-7
SponsorTanta University

About this trial

To assess \& compare clinical \& radiographic effects of Eggshell Powder, Biodentine and MTA as pulpotomy agents in primary teeth.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Restorable primary molars with deep carious lesions.

Absence of gingival swelling or sinus tract.

Absence of spontaneous pain

Absence of pain on percussion.

Disqualifiers

presence of spontaneous pain

presence of gingival swelling or sinus tract

presence of internal or external root resorption

pain on percussion.

Trial design

Design model

Parallel

Treatments tested in this trial

  • pulpotomy

    Procedure/Surgery

    Teeth will be anesthetized then Rubber dam and high suction will be used in pulpotomy procedure. Cavity outline was performed by sterile #330 high speed bur using water spray. Caries was removed by large spoon excavator. When pulpal exposure occurred, the roof of pulp chamber removed by low speed round bur. Haemostasis was obtained by applying pressure with moist cotton pellet with saline. Then the test materials was applied. after that, pulp stumps of all molars in each group will be dressed using Intermediate restorative material then the tooth will be restored with a preformed stainless steel crown

  • cone beam computed tomography (CBCT) assessment

    Radiation

    a post-operative CBCT image will be taken immediately after completing the procedure with fixed exposure parameters (120 Kv, 5mA, and 0.125mm voxel size) using the smallest field of view (8D, 8Hcm) also, after 12 months follow-up periods.

Treatment groups

30 Participants
are divided into 3 treatment groups
Group A: group 1: Eggshell PowderExperimental treatment 2 interventions
Group B: group II: biodentineExperimental treatment 2 interventions
Group C: group III: mineral tri-oxide aggregate (MTA)Active comparator 2 interventions

Trial outcomes

Primary outcomes

1

absence of pain

Measuring Method: Verbal Question to Patient /Parents Measuring Unite: score 0 for absence of pain and score 1 for presence of pain

Time frame
up to 12 months
2

absence of fistula

Measuring Method: Visual examination by operator Measuring Unite: score 0 for absence of swelling and score 1 for presence of swelling

Time frame
up to 12 months
3

Tenderness to percussion

Measuring Method: Percussion test Measuring Unite: Binary (+/-)

Time frame
Up to 12 month
4

Furcation radiolucency

Measuring Method: cone beam computed tomography (CBCT) for assessment of radio-density of bone at the furcation area Measuring Unite: Binary (+/-)

Time frame
6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tanta University

Lead sponsor

Source ClinicalTrials.gov
Apply now